{"id":1820,"date":"2005-10-01T12:03:00","date_gmt":"2005-10-01T10:03:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2005\/vorhofflimmern-durch-medikamente-ausgeloest"},"modified":"2022-03-17T14:10:52","modified_gmt":"2022-03-17T13:10:52","slug":"vorhofflimmern-durch-medikamente-ausgeloest","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2005\/vorhofflimmern-durch-medikamente-ausgeloest","title":{"rendered":"Vorhofflimmern &#8211; durch Medikamente ausgel\u00f6st"},"content":{"rendered":"<p>Bei der Analyse der Ursachen von Vorhofflimmern werden h\u00e4ufig sehr aufw\u00e4ndige apparative Untersuchungen durchgef\u00fchrt. Dabei werden unerw\u00fcnschte Arzneimittelwirkungen (UAW) als Ausl\u00f6ser h\u00e4ufig au\u00dfer Acht gelassen, meist wohl aus Unkenntnis. W\u00e4hrend es z.B. von Betasympathikomimetika und Theophyllinen bekannt ist, dass sie Vorhofflimmern ausl\u00f6sen k\u00f6nnen, ist dies von Digitalis, Thiazid-Diuretika und Nitraten weit weniger gel\u00e4ufig und von [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bei der Analyse der Ursachen von Vorhofflimmern werden h\u00e4ufig sehr aufw\u00e4ndige apparative Untersuchungen durchgef\u00fchrt. Dabei werden unerw\u00fcnschte Arzneimittelwirkungen (UAW) als Ausl\u00f6ser h\u00e4ufig au\u00dfer Acht gelassen, meist wohl aus Unkenntnis. W\u00e4hrend es z.B. von Betasympathikomimetika und Theophyllinen bekannt ist, dass sie Vorhofflimmern ausl\u00f6sen k\u00f6nnen, ist dies von Digitalis, Thiazid-Diuretika und Nitraten weit weniger gel\u00e4ufig und von [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[268,185,4018,1746,1256,4014,28,4019,616,316,309,312,314,313,315,808,184,317,320,311,307,319,310,351,3269,239,4015,30,73,913,178,491,1494,1638,274,1069,1917,4017,1891,392,4016,920,270,187,710,4023,4021,4022,641,169,4024,321,3169,286,250,1644,664,403,662,4026,4020,4027,3093,1756,4025,183,306,381,378,806,377,4013,3076,3085,437,1940,756,228,4012,181],"class_list":["post-1820","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-5-fluorouracil","tag-absolute-arrhythmie","tag-acetylcholin","tag-adenosin","tag-albuterol","tag-alizaprid","tag-amifostin","tag-aminophyllin","tag-amphotericin-b","tag-angiotensin-ii-antagonisten","tag-angiotensin-ii-blocker","tag-angiotensin-ii-inhibitoren","tag-angiotensin-ii-rezeptor-antagonisten","tag-angiotensin-ii-rezeptor-blocker","tag-angiotensin-ii-rezeptor-inhibitoren","tag-apomorphin","tag-arrhythmien","tag-at-ii-antagonisten","tag-at-ii-blocker","tag-at-ii-inhibitoren","tag-at-ii-rezeptor-antagonisten","tag-at-ii-rezeptor-blocker","tag-at-ii-rezeptor-inhibitoren","tag-atenolol","tag-atropin","tag-azathioprin","tag-bupivacain","tag-cisplatin","tag-clopidogrel","tag-clozapin","tag-digoxin","tag-diltiazem","tag-disulfiram","tag-dobutamin","tag-docetaxel","tag-donepezil","tag-dopamin","tag-dopexamin","tag-etanercept","tag-etoposid","tag-fluorescein","tag-fluoxetin","tag-gemcitabin","tag-herzrhythmusstoerungen","tag-ifosfamid","tag-interferon-gamma","tag-interleukin-3","tag-interleukin-6","tag-isosorbidmononitrat","tag-kalzium","tag-levocarnitin","tag-losartan","tag-magnesiumsulfat","tag-melphalan","tag-methylprednisolon","tag-nesiritid","tag-niacin","tag-nikotin","tag-nikotinsaeure","tag-pentagastrin","tag-perflexan","tag-perfluorobutan","tag-physostigmin","tag-porfimer","tag-pseudoephedrin","tag-rhythmusstoerungen","tag-sartane","tag-selektive-serotonin-wiederaufnahme-hemmer","tag-serotonin-wiederaufnahme-hemmer","tag-sildenafil","tag-ssri","tag-steroide","tag-sumatriptan","tag-terbutalin","tag-thiazide","tag-tranylcypromin","tag-trazodon","tag-verapamil","tag-verteporfin","tag-vorhofflimmern"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1820","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1820"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1820\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1820"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1820"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1820"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}